BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Indoco Remedies Ltd. Share Price

NSE
BSE

NSE : INDOCO

BSE : 532612

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹224.21

High

₹228.25

Price Summary

Previous Close ₹224.60
Day's Range ₹224.21 - ₹228.25
Open ₹228.25
52 Week Range ₹162.19 - ₹349.80
Volume 9,436
Market Cap ₹0.00
Previous Close ₹223.95
Day's Range ₹223.50 - ₹227.50
Open ₹225.30
52 Week Range ₹163.70 - ₹348.10
Volume 1,096
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 21.19
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.09
Price/Earning (TTM) 0.00
TTM EPS (₹) -10.31
P/E Ratio 0.00
Book Value(₹) 2.22
PAT Margin (%) -4.68
Face Value (₹) 2.00
ROCE(%) -0.43
Trade Value ( ₹ in Lacs) 2.45
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.09
Price/Earning (TTM) 0.00
TTM EPS (₹) -10.31
P/E Ratio 0.00
Book Value(₹) 2.22
PAT Margin (%) -4.68
Face Value (₹) 2.00
ROCE(%) -0.43

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 15181.9 3472.5
Expenses N/A N/A
PBT -73.7 -309.0
Operating profit 0.0 0.0
Net profit -87.3 -262.4

Shareholding Pattern

Promoters (% Holding)

58.86%

Mutual funds (% Holding)

17.54%

Non-Institution (% Holding)

22.04%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.94%

About Indoco Remedies Ltd.

Founded 1947
Managing Director Aditi Panandikar
NSE Symbol INDOCO

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,37,734.67 1,843.15 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,80,311.57 6,855.75 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,45,369.09 4,348.45 3,102.00 - 3,102.00
Apollo Hospitals Enterprise Ltd. 1,15,044.98 8,143.50 6,696.50 - 6,696.50
Cipla Ltd. 1,07,204.87 1,416.05 1,165.70 - 1,165.70
Dr. Reddy's Laboratories Ltd. 1,05,592.45 1,270.55 1,148.40 - 1,148.40
Lupin Ltd. 1,01,293.89 2,227.55 1,836.80 - 1,836.80
Max Healthcare Institute Ltd. 99,791.55 1,035.05 903.00 - 903.00
Mankind Pharma Ltd. 99,384.29 2,427.55 1,909.70 - 1,909.70
Zydus Lifesciences Ltd. 94,480.34 983.00 835.50 - 835.50
no-content No Records Found

Latest News

May
11
2026
EQUITY Posted on May 11th 2026

Indoco Remedies informs about transcript of conference call

Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Indoco Remedies has informed that it enclosed the transcript of Earnings Conference Call held on 07th May, 2026 at 03:30 pm (IST) in respect of Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended 31st March, 2026. The Earnings Conference Call concluded at 04:23 pm (IST) on 07th May, 2026.

The above information is a part of company’s filings submitted to BSE.
Read More
May
14
2026
COMPANY Posted on May 14th 2026

Cipla - Quaterly Results

A decrease in the sales to Rs. 42099.80 millions was observed for the quarter ended March 2026. The sales stood at Rs. 47978.90 millions during the similar quarter previous year.A big decline of -74.11% was reported for the quarter ended March 2026 to Rs. 3846.40  millions from Rs. 14854.00 millions of corresponding previous quarter.Operating Profit reported a sharp decline to 7783.30 millions from 16120.80 millions in the corresponding previous quarter.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 42099.80 47978.90 -12.25 189799.50 190448.50 -0.34 189799.50 190448.50 -0.34
Other Income 1802.20 2933.70 -38.57 11226.50 9847.20 14.01 11226.50 9847.20 14.01
PBIDT 7783.30 16120.80 -51.72 55890.40 67631.60 -17.36 55890.40 67631.60 -17.36
Interest 67.40 34.90 93.12 193.00 151.10 27.73 193.00 151.10 27.73
PBDT 7715.90 19032.50 -59.46 53253.70 70427.10 -24.38 53253.70 70427.10 -24.38
Depreciation 2491.10 1477.00 68.66 6894.30 5738.90 20.13 6894.30 5738.90 20.13
PBT 5224.80 17555.50 -70.24 46359.40 64688.20 -28.33 46359.40 64688.20 -28.33
TAX 1378.40 2701.50 -48.98 11207.60 13111.70 -14.52 11207.60 13111.70 -14.52
Deferred Tax 180.70 -625.60 -128.88 188.60 -491.50 -138.37 188.60 -491.50 -138.37
PAT 3846.40 14854.00 -74.11 35151.80 51576.50 -31.85 35151.80 51576.50 -31.85
Equity 1615.60 1615.20 0.02 1615.60 1615.20 0.02 1615.60 1615.20 0.02
PBIDTM(%) 18.49 33.60 -44.98 29.45 35.51 -17.08 29.45 35.51 -17.08
Read More
May
14
2026
COMPANY Posted on May 14th 2026

Metropolis Health. - Quaterly Results

The company witnessed a 12.94% growth in the revenue at Rs. 3520.31 millions for the quarter ended March 2026 as compared to Rs. 3116.86 millions during the year-ago period.The Profit  for the quarter ended March 2026 of  Rs. 432.61  millions  grew by 82.64% from Rs. 236.86 millions.The company reported a good operating profit of 989.70 millions compared to 601.16 millions of corresponding previous quarter.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 3520.31 3116.86 12.94 13654.72 12157.52 12.32 13654.72 12157.52 12.32
Other Income 88.17 75.96 16.07 163.31 170.47 -4.20 163.31 170.47 -4.20
PBIDT 989.70 601.16 64.63 3545.54 2845.63 24.60 3545.54 2845.63 24.60
Interest 65.61 44.26 48.24 191.87 182.60 5.08 191.87 182.60 5.08
PBDT 924.09 556.90 65.93 3274.10 2663.03 22.95 3274.10 2663.03 22.95
Depreciation 327.97 272.75 20.25 1161.67 1048.86 10.76 1161.67 1048.86 10.76
PBT 596.12 284.15 109.79 2112.43 1614.17 30.87 2112.43 1614.17 30.87
TAX 163.51 47.29 245.76 541.02 370.75 45.93 541.02 370.75 45.93
Deferred Tax -25.45 -14.47 75.88 -34.54 -24.37 41.73 -34.54 -24.37 41.73
PAT 432.61 236.86 82.64 1571.41 1243.42 26.38 1571.41 1243.42 26.38
Equity 414.66 103.60 300.25 414.66 103.60 300.25 414.66 103.60 300.25
PBIDTM(%) 28.11 19.29 45.76 25.97 23.41 10.93 25.97 23.41 10.93
Read More
May
14
2026
COMPANY Posted on May 14th 2026

Smruthi Organics - Quaterly Results

The sales slipped to Rs. 290.89 millions for the March 2026 quarter as against Rs. 380.94 millions during the year-ago period.The Net Profit of the company slipped to Rs. 10.65 millions from Rs. 22.30 millions, a decline of -52.24% on QoQ basis.Operating Profit reported a sharp decline to 38.12 millions from 47.55 millions in the corresponding previous quarter.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 290.89 380.94 -23.64 1019.67 1260.08 -19.08 1019.67 1260.08 -19.08
Other Income 0.17 0.76 -77.63 1.24 0.89 39.33 1.24 0.89 39.33
PBIDT 38.12 47.55 -19.83 131.59 122.71 7.24 131.59 122.71 7.24
Interest 3.11 5.16 -39.73 16.84 18.70 -9.95 16.84 18.70 -9.95
PBDT 34.90 42.39 -17.67 110.12 104.01 5.87 110.12 104.01 5.87
Depreciation 17.53 15.04 16.56 63.49 55.01 15.42 63.49 55.01 15.42
PBT 17.37 27.35 -36.49 46.63 49.00 -4.84 46.63 49.00 -4.84
TAX 6.72 5.05 33.07 12.39 13.37 -7.33 12.39 13.37 -7.33
Deferred Tax 0.52 0.19 173.68 -2.00 -0.32 525.00 -2.00 -0.32 525.00
PAT 10.65 22.30 -52.24 34.24 35.63 -3.90 34.24 35.63 -3.90
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 13.10 12.48 4.99 12.91 9.74 32.52 12.91 9.74 32.52
Read More
May
14
2026
COMPANY Posted on May 14th 2026

Onesource Specialty - Quaterly Results

Net sales declined -12.24%  to  Rs. 4189.62 million from Rs. 4774.14 millions.The company suffered a huge decline of -87.72% to Rs. 214.79  millions from Rs. 1748.77 millions  of corresponding previous quarter.A decline of 767.99 millions was observed in the OP in the quarter ended March 2026 from 2408.65 millions on QoQ basis.
(Rs. in Million)
  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 4189.62 4774.14 -12.24 14053.81 12995.89 8.14 14053.81 12995.89 8.14
Other Income 20.93 39.09 -46.46 150.08 176.82 -15.12 150.08 176.82 -15.12
PBIDT 767.99 2408.65 -68.12 2840.01 3869.57 -26.61 2840.01 3869.57 -26.61
Interest 222.52 323.94 -31.31 1205.76 1616.50 -25.41 1205.76 1616.50 -25.41
PBDT 562.17 2084.71 -73.03 1580.05 1130.57 39.76 1580.05 1130.57 39.76
Depreciation 347.38 335.94 3.41 1367.95 1345.12 1.70 1367.95 1345.12 1.70
PBT 214.79 1748.77 -87.72 212.10 -214.55 -198.86 212.10 -214.55 -198.86
TAX 0.00 0.00 0.00 0.00 -414.55 0.00 0.00 -414.55 0.00
Deferred Tax 0.00 0.00 0.00 0.00 -414.55 0.00 0.00 -414.55 0.00
PAT 214.79 1748.77 -87.72 212.10 200.00 6.05 212.10 200.00 6.05
Equity 114.62 114.43 0.17 114.62 114.43 0.17 114.62 114.43 0.17
PBIDTM(%) 18.33 50.45 -63.67 20.21 29.78 -32.13 20.21 29.78 -32.13
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Indoco Remedies Ltd. ?

The current share price of Indoco Remedies Ltd. is ₹224.60 as of 2026-05-14.

The market capitalisation of Indoco Remedies Ltd. is ₹2,086.06 as of 2026-05-13.

The 1-year return of Indoco Remedies Ltd. is -1.37% as of 2026-05-14.

The P/E ratio of Indoco Remedies Ltd. is 0.00 as of 2026-05-14.

The 52-week high and low of Indoco Remedies Ltd. are ₹349.80 and ₹162.19, respectively, as of 2026-05-14.

The dividend yield of Indoco Remedies Ltd. is 0.0885% as of2026-05-13.

You can buy Indoco Remedies Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Indoco Remedies Ltd. is Aditi Panandikar.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore